Digital support for breast cancer treatment adherence
PACED-Patient-centred Digital Support During Adjuvant Endocrine Breast Cancer Treatment
This study is testing if a digital support app can help women with hormone receptor positive breast cancer stick to their treatment and feel better after their therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Region Stockholm Government |
| Locations | 3 sites (Stockholm and 2 other locations) |
| Trial ID | NCT05084625 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of a digital support app on patients with hormone receptor positive breast cancer undergoing adjuvant endocrine therapy. After completing adjuvant radiotherapy, participants will be randomly assigned to receive either 12 months of access to the app alongside standard follow-up or standard follow-up alone. The research aims to determine if the app can reduce late side effects, enhance quality of life, and improve adherence to treatment protocols.
Who should consider this trial
Good fit: Ideal candidates are patients with hormone receptor positive breast cancer who have recently started adjuvant endocrine treatment.
Not a fit: Patients who are cognitively impaired, lack access to a mobile phone or internet, or do not understand Swedish may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment adherence and quality of life for breast cancer patients.
How similar studies have performed: Other studies have shown promising results with digital support interventions in improving treatment adherence and patient outcomes, suggesting this approach is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hormone receptor positive breast cancer * On adjuvant endocrine treatment 0-16 weeks ago Exclusion Criteria: * Cognitively impaired * No access to a mobile phone or internet * Not understanding Swedish
Where this trial is running
Stockholm and 2 other locations
- Karolinska University Hospital — Stockholm, Sweden (Not_yet_recruiting)
- Oncology department Capio St Gorans Hospital — Stockholm, Sweden (Recruiting)
- Södersjukhuset — Stockholm, Sweden (Not_yet_recruiting)
Study contacts
- Principal investigator: Jenny Bergqvist — St Gorans Hospital
- Study coordinator: Jenny Bergqvist
- Email: jenny.bergqvist@ki.se
- Phone: +46700891524
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.